SIRT1 and Cognitive impairment: The correlation between clinical biomarkers and the SIRT1 levels presented in Table 4 reveals that a significant negative correlation was observed in the Severe-Moderate Cognitive Impairment group (p < 0.05), while a significant positive correlation occurred in the Normal Cognitive group (p < 0.05).